Ceapro Inc. (Ceapro) is a biotechnology company. The Company is engaged in the development and commercialization of natural products for personal care, cosmetic, medical and animal health industries using technology and natural, renewable resources. The Company�s products include beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides and lupin peptides, which are marketed to the personal care, cosmetic, medical, and animal health industries through the Company�s distribution partners and direct sales. The Company�s veterinary therapeutic product includes an oat shampoo, an ear cleanser and a dermal complex/conditioner, which are manufactured and marketed to veterinarians in Japan and Asia, through agreements with Daisen Sangyo Co. Ltd. The Company�s subsidiaries include Ceapro Technology Inc., Ceapro Veterinary Products Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc. and Ceapro USA Inc.